PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
City of Hope Medical Center, Duarte, California Mayo Clinic in Florida, Jacksonville, Florida Northwell Health Cancer Institute at Huntington, Greenlawn, New York Last updated December 2025